Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Ampicillin Sodium: Benchmark Data & Mechanistic Insights ...

    2025-10-29

    Ampicillin Sodium: Benchmark Data & Mechanistic Insights for β-Lactam Antibiotic Research

    Executive Summary: Ampicillin sodium (CAS 69-52-3) is a water-soluble β-lactam antibiotic that competitively inhibits bacterial transpeptidase enzymes, thereby disrupting cell wall biosynthesis and causing cell lysis in both Gram-positive and Gram-negative bacteria (ApexBio product page). Its antibacterial activity is robustly quantified with an IC50 of 1.8 μg/ml and a MIC of 3.1 μg/ml in E. coli 146 cells under defined laboratory conditions. It is widely employed in antibacterial activity assays, animal infection models, and antibiotic resistance research, with a purity of ≥98% supported by NMR, MS, and COA quality control. Ampicillin sodium is referenced in recombinant protein workflows, such as annexin V expression and purification, due to its reliable selection properties (Burger et al., 1993, FEBS Letters).

    Biological Rationale

    Ampicillin sodium is a semi-synthetic β-lactam antibiotic structurally related to penicillin. It is used to target the synthesis of bacterial cell walls—an essential process for bacterial viability. The bacterial cell wall is especially crucial in both Gram-positive and Gram-negative organisms, where it provides mechanical strength and protection against osmotic lysis. The β-lactam ring of ampicillin is key to its function: it mimics the D-Ala-D-Ala terminus of peptidoglycan precursors, allowing the drug to bind transpeptidases (penicillin-binding proteins, PBPs). This interaction disrupts peptidoglycan cross-linking, thereby weakening the bacterial cell wall and leading to cell death (Mechanistic Insights and Antibacterial Assays—this article extends the scope by providing fresh benchmarks and experimental parameters). Ampicillin sodium's broad-spectrum activity makes it a cornerstone in both basic and applied microbiology labs for selection and antibacterial efficacy evaluation.

    Mechanism of Action of Ampicillin sodium

    Ampicillin sodium exerts its effect by competitively inhibiting the transpeptidase enzymes responsible for the final stages of bacterial cell wall biosynthesis. Specifically, it binds to the active site of PBPs, preventing the cross-linking of the peptidoglycan polymer that forms the rigid cell wall structure. This inhibition is both rapid and concentration-dependent. The loss of proper cell wall integrity results in increased susceptibility to osmotic pressure and, ultimately, cell lysis. Ampicillin sodium is effective against a range of Gram-positive and Gram-negative bacteria, reflecting its ability to penetrate outer membranes and interact with diverse PBPs (Translational Research Mechanistic Overview—this article adds new data on solubility and application boundaries). Mechanistically, ampicillin's β-lactam ring is essential for its covalent acylation of the transpeptidase active site, a process confirmed by structural and biochemical analyses.

    Evidence & Benchmarks

    • Shows an IC50 of 1.8 μg/ml for transpeptidase inhibition in E. coli 146 cells at 37°C, pH 7.2 (ApexBio product data, https://www.apexbt.com/ampicillin-sodium.html).
    • Minimum inhibitory concentration (MIC) is 3.1 μg/ml for E. coli under defined laboratory conditions (ApexBio, product page).
    • Supports selection of recombinant E. coli in protein expression workflows—demonstrated in annexin V purification protocols using 50 μg/ml in LB media (Burger et al., 1993, FEBS Letters).
    • Water solubility is quantified at ≥18.57 mg/mL; in DMSO at ≥73.6 mg/mL; in ethanol at ≥75.2 mg/mL, allowing for flexible stock preparation (ApexBio, product page).
    • Purity of ≥98% routinely validated by NMR, MS, and certificate of analysis (COA) documentation (ApexBio, product page).
    • Ampicillin sodium is stable when stored at -20°C and is shipped with blue ice to maintain integrity for small molecule research (ApexBio, product page).

    Applications, Limits & Misconceptions

    Ampicillin sodium is a gold standard for antibacterial activity assays, resistance development studies, and as a selective agent in recombinant protein workflows. It is widely used to model infection in animal studies and in vitro antibacterial efficacy. The compound's predictable solubility and high purity support reproducibility in mechanistic and translational research. See Optimizing Antibacterial Activity Assays for stepwise protocols—this article updates critical solubility and stability parameters for advanced users.

    Common Pitfalls or Misconceptions

    • Not effective against β-lactamase-producing bacteria: Ampicillin sodium is hydrolyzed by most bacterial β-lactamases and is therefore ineffective against resistant strains unless combined with an appropriate inhibitor.
    • Improper storage reduces efficacy: Stock solutions degrade rapidly at room temperature or above 4°C; always store at -20°C and avoid repeated freeze-thaw cycles.
    • Long-term solution storage is not recommended: Use freshly prepared solutions for each experiment, as potency may decline over days even at low temperatures.
    • Does not inhibit all Gram-negative species: Some Gram-negative bacteria possess outer membrane permeability barriers or efflux pumps that diminish ampicillin activity.
    • Incompatibility with certain media components: Complex media or those containing high concentrations of divalent cations may reduce drug activity.

    Workflow Integration & Parameters

    Ampicillin sodium is integrated into research workflows for both selection and antibacterial testing. In recombinant protein expression, such as annexin V production in E. coli W3110, 50 μg/ml ampicillin sodium is added to LB media to maintain selection for plasmid-bearing bacteria (Burger et al., 1993). For antibacterial activity assays, researchers commonly prepare solutions in water, DMSO, or ethanol at concentrations matching assay requirements. Standard protocols recommend using freshly prepared solutions and monitoring the temperature during storage and shipping (ApexBio, product page).

    For advanced troubleshooting, see Optimizing Antibacterial Assays & Resistance Studies—this article extends troubleshooting guidelines to include stability and compatibility criteria for Ampicillin sodium.

    Conclusion & Outlook

    Ampicillin sodium remains an indispensable tool for microbiology, antibiotic resistance, and recombinant protein research. Its well-characterized mechanism, defined activity benchmarks, and reliable performance support its ongoing use for cell wall biosynthesis inhibition studies. Ongoing development of β-lactamase inhibitors and new derivatives will further expand its utility in resistance research and translational applications. For product-specific details and verified protocols, consult the Ampicillin sodium (A2510) product page.